OMER Q1 2019 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M+1271.5% YoY

Gross Profit

$22M99.4% margin

Operating Income

-$19M-88.3% margin

Net Income

-$24M-111.8% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

-1.1%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$101M

Total Liabilities

$222M

Stockholders' Equity

-$121M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$2M	+1271.5%
Gross Profit	$22M	$1M	+1463.0%
Operating Income	-$19M	-$28M	+30.5%
Net Income	-$24M	-$30M	+19.0%